COX-2: A Pivotal Enzyme in Mucosal Protection and Resolution of Inflammation
The discovery of a second form of cyclooxygenase, COX-2, led to a burst of research aimed at the development of nonsteroidal anti-inflammatory drugs that would not damage the gastrointestinal tract. In the years since, this promise has only been partially fulfilled. Selective COX-2 inhibitors cause...
Saved in:
| Main Author: | John L. Wallace |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2006.122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interaction Phloroglucinol as inflammation therapy through Cyclooxygenase-2 (COX-2) gene inhibition
by: Yohanes Bare
Published: (2022-03-01) -
Microbiota in Chronic Mucosal Inflammation
by: G. Gerhard Rogler, et al.
Published: (2010-01-01) -
Density Functional Theory and Molecular Docking Investigation of Selected NSAIDs against COX-1 and COX-2 Enzymes: Study of Correlation Between Computational and Experimental Results
by: Ateeq Ullah Jan, et al.
Published: (2025-04-01) -
Homocysteine aggravates intestinal inflammation through promotion of 5-LOX and COX-2 in IBD
by: Jing Wang, et al.
Published: (2024-11-01) -
Nitric oxide as a mediator of gastrointestinal mucosal injury?—Say it ain't so
by: Paul Kubes, et al.
Published: (1995-01-01)